It has been reported that increased FGF-2 levels are related to psychiatric disorders and may act as a predisposing factor for anxiety and as a modulator of environmental influences on stress behavior, whereas elevated levels of EGF are implicated in psychotic symptoms through deregulation of dopaminergic signaling [60,61,62]. The gene discussed is EGF; the disease is psychiatric disorder.